190 related articles for article (PubMed ID: 22442169)
21. Strategies used by hospitals to improve speed of tissue-type plasminogen activator treatment in acute ischemic stroke.
Xian Y; Smith EE; Zhao X; Peterson ED; Olson DM; Hernandez AF; Bhatt DL; Saver JL; Schwamm LH; Fonarow GC
Stroke; 2014 May; 45(5):1387-95. PubMed ID: 24713527
[TBL] [Abstract][Full Text] [Related]
22. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
[TBL] [Abstract][Full Text] [Related]
23. Reducing in-hospital delay to 20 minutes in stroke thrombolysis.
Meretoja A; Strbian D; Mustanoja S; Tatlisumak T; Lindsberg PJ; Kaste M
Neurology; 2012 Jul; 79(4):306-13. PubMed ID: 22622858
[TBL] [Abstract][Full Text] [Related]
24. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
[TBL] [Abstract][Full Text] [Related]
25. Predictors of increased intravenous tissue plasminogen activator use among hospitals participating in the Massachusetts Primary Stroke Service Program.
Rost NS; Smith EE; Pervez MA; Mello P; Dreyer P; Schwamm LH
Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):314-20. PubMed ID: 22534407
[TBL] [Abstract][Full Text] [Related]
26. Predictive value of the Cincinnati Prehospital Stroke Scale for identifying thrombolytic candidates in acute ischemic stroke.
You JS; Chung SP; Chung HS; Lee HS; Park JW; Kim HJ; Lee SH; Park I; Lee HS
Am J Emerg Med; 2013 Dec; 31(12):1699-702. PubMed ID: 24055479
[TBL] [Abstract][Full Text] [Related]
27. Use of tissue-type plasminogen activator before and after publication of the European Cooperative Acute Stroke Study III in Get With The Guidelines-Stroke.
Messé SR; Fonarow GC; Smith EE; Kaltenbach L; Olson DM; Kasner SE; Schwamm LH
Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):321-6. PubMed ID: 22550132
[TBL] [Abstract][Full Text] [Related]
28. Is Door-to-Needle Time Reduced for Emergency Medical Services Transported Stroke Patients Routed Directly to the Computed Tomography Scanner on Emergency Department Arrival?
Sloane B; Bosson N; Sanossian N; Saver JL; Perez L; Gausche-Hill M
J Stroke Cerebrovasc Dis; 2020 Jan; 29(1):104477. PubMed ID: 31699573
[TBL] [Abstract][Full Text] [Related]
29. Times from symptom onset to hospital arrival in the Get with the Guidelines--Stroke Program 2002 to 2009: temporal trends and implications.
Tong D; Reeves MJ; Hernandez AF; Zhao X; Olson DM; Fonarow GC; Schwamm LH; Smith EE
Stroke; 2012 Jul; 43(7):1912-7. PubMed ID: 22539544
[TBL] [Abstract][Full Text] [Related]
30. Adherence to guidelines by emergency medical services during transport of stroke patients receiving intravenous thrombolytic infusion.
Asaithambi G; Chaudhry SA; Hassan AE; Rodriguez GJ; Suri MF; Qureshi AI
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e42-5. PubMed ID: 22572162
[TBL] [Abstract][Full Text] [Related]
31. Hospital prenotification of stroke patients by emergency medical services improves stroke time targets.
McKinney JS; Mylavarapu K; Lane J; Roberts V; Ohman-Strickland P; Merlin MA
J Stroke Cerebrovasc Dis; 2013 Feb; 22(2):113-8. PubMed ID: 21820919
[TBL] [Abstract][Full Text] [Related]
32. Drill down analysis of door-to-needle time of acute ischemic stroke patients treated with intravenous tissue plasminogen activator.
Schrock JW; Lum M
Am J Emerg Med; 2014 Nov; 32(11):1330-3. PubMed ID: 25195044
[TBL] [Abstract][Full Text] [Related]
33. Safety and effectiveness of endovascular treatment after 6 hours of symptom onset in patients with anterior circulation ischemic stroke: a matched case control study.
Qureshi AI; Miley JT; Chaudhry SA; Semaan E; Rodriguez GJ; Suri MF; Adams HP
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1076-81. PubMed ID: 23099041
[TBL] [Abstract][Full Text] [Related]
34. Posterior circulation stroke is associated with prolonged door-to-needle time.
Sarraj A; Medrek S; Albright K; Martin-Schild S; Bibars W; Vahidy F; Grotta JC; Savitz SI
Int J Stroke; 2015 Jul; 10(5):672-8. PubMed ID: 23521891
[TBL] [Abstract][Full Text] [Related]
35. Does study enrollment delay treatment with intravenous thrombolytics for acute ischemic stroke?
Martin-Schild S; Albright KC; Hallevi H; Barreto AD; Grotta JC; Savitz SI
Stroke; 2009 Feb; 40(2):663. PubMed ID: 18948603
[TBL] [Abstract][Full Text] [Related]
36. Twelve-month experience of acute stroke thrombolysis in Christchurch, New Zealand: emergency department screening and acute stroke service treatment.
Fink J
N Z Med J; 2005 May; 118(1214):U1430. PubMed ID: 15886726
[TBL] [Abstract][Full Text] [Related]
37. Door-in-Door-out Times for Interhospital Transfer of Patients With Stroke.
Stamm B; Royan R; Giurcanu M; Messe SR; Jauch EC; Prabhakaran S
JAMA; 2023 Aug; 330(7):636-649. PubMed ID: 37581671
[TBL] [Abstract][Full Text] [Related]
38. A systemized stroke code significantly reduced time intervals for using intravenous tissue plasminogen activator under magnetic resonance imaging screening.
Sohn SW; Park HS; Cha JK; Nah HW; Kim DH; Kang MJ; Choi JH; Huh JT
J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):465-72. PubMed ID: 25524016
[TBL] [Abstract][Full Text] [Related]
39. Quality assurance monitoring of a citywide transportation protocol improves clinical indicators of intravenous tissue plasminogen activator therapy: a community-based, longitudinal study.
Atsumi C; Hasegawa Y; Tsumura K; Ueda T; Suzuki K; Sugiyama M; Nozaki H; Suzuki S; Nakane M; Nagashima G; Kitamura T; Nikaido H; Sasanuma J
J Stroke Cerebrovasc Dis; 2015 Jan; 24(1):183-8. PubMed ID: 25440326
[TBL] [Abstract][Full Text] [Related]
40. Thrombolysis for acute ischemic stroke: do patients treated out of hours have a worse outcome?
Fang K; Churilov L; Weir L; Dong Q; Davis S; Yan B
J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):427-32. PubMed ID: 23635920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
